Trial
NCT04743739
Rituximab Combined With Cyclosporine Versus Rituximab Alone in the Treatment of iMN
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Peking Union Medical College Hospital
Collaborators
Beijing Tongren Hospital; Chinese Academy of Medical Sciences, Fuwai Hospital; The Luhe Teaching Hospital of the Capital Medical University; The Seventh Affiliated Hospital of Sun Yat-sen University; First Affiliated Hospital of Xinjiang Medical University; Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Condition
Idiopathic Membranous Nephropathy
Intervention
Rituximab
Why stopped
insufficient patient enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-09